KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Biogen (BIIB) Shares Outstanding (2016 - 2022)

Historic Shares Outstanding for Biogen (BIIB) over the last 14 years, with Q4 2022 value amounting to $167.9 million.

  • Biogen's Shares Outstanding fell 169.79% to $167.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was $167.9 million, marking a year-over-year decrease of 169.79%. This contributed to the annual value of $167.9 million for FY2022, which is 169.79% down from last year.
  • As of Q4 2022, Biogen's Shares Outstanding stood at $167.9 million, which was down 169.79% from $170.8 million recorded in Q4 2021.
  • In the past 5 years, Biogen's Shares Outstanding ranged from a high of $225.2 million in Q2 2018 and a low of $167.9 million during Q4 2022
  • Moreover, its 5-year median value for Shares Outstanding was $207.2 million (2019), whereas its average is $201.6 million.
  • In the last 5 years, Biogen's Shares Outstanding skyrocketed by 379.15% in 2019 and then crashed by 1273.97% in 2020.
  • Biogen's Shares Outstanding (Quarter) stood at $221.0 million in 2018, then dropped by 10.41% to $198.0 million in 2019, then fell by 11.01% to $176.2 million in 2020, then fell by 3.06% to $170.8 million in 2021, then dropped by 1.7% to $167.9 million in 2022.
  • Its Shares Outstanding stands at $167.9 million for Q4 2022, versus $170.8 million for Q4 2021 and $176.2 million for Q4 2020.